Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks544445-BOM
resources
544445-BOM

Asston Pharmaceuticals Ltd.

BSE: 544445
SME
Sector: Healthcare
Industry: Pharmaceuticals
86.00+1.5 (+1.74%)
24 Aug, 2:59 PM

Annual Reports and Financial Documents

Asston Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20252026
Annual ReportsFY 2025—
Quarterly Results
Conference Calls——
Presentations——

Corporate Announcements and Regulatory Filings

Asston Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. EGM3 Aug 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
    Voting Result and Scrutinizer report for EGM held on 31st July, 2026 through VC-OAVM
  2. EGM31 Jul 2026
    Shareholder Meeting / Postal Ballot-Outcome of EGM
    Outcome and Proceedings of the 2nd Extraordinary General Meeting for F.Y. 2026-27, scheduled to be held on 31st July, 2026, at 12:30 P.M. through Video Conferencing and Other Audio-Visual Means.
  3. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201814 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under regulation 74(5) of SEBI (Depositories Participants) Regulation, 2018.
  4. Newspaper Publication10 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication
  5. EGM9 Jul 2026
    Notice Of Second Extraordinary General Meeting For F.Y. 2026-27 Scheduled To Be Held On 31St July, 2026 At 12:30 PM
    Notice of Second Extraordinary General Meeting for F.Y. 2026-27
  6. Meeting Updates2 Jul 2026
    Announcement under Regulation 30 (LODR)-Meeting Updates
    Meeting Update
  7. EGM2 Jul 2026
    Announcement Regarding Extraordinary General Meeting Of The Company.
    Announcement regarding Extraordinary General Meeting of the Company.
  8. General2 Jul 2026
    Update On Board Meeting Scheduled To Be Held On 02Nd July, 2026.
    Update on Board Meeting Scheduled to be held on 02nd July, 2026.
  9. Preferential Issue2 Jul 2026
    Announcement under Regulation 30 (LODR)-Preferential Issue
    Disclosure under regulation 30 (LODR)- Preferential Issue
  10. Outcome of Board Meeting2 Jul 2026
    Board Meeting Outcome for Outcome Of The Board Meeting Scheduled To Be Held On 02Nd July, 2026.
    Outcome of the Board Meeting Scheduled to be held on 02nd July, 2026.
  11. Closure of Trading Window24 Jun 2026
    Closure of Trading Window
    Trading Window Closure
  12. Board Meeting24 Jun 2026
    Board Meeting Intimation for Board Meeting Intimation
    Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/07/2026 ,inter alia, to consider and approve proposal for raising ....
  13. Outcome of Board Meeting29 May 2026
    Board Meeting Outcome for Outcome Of The Board Meeting Held On 29Th May, 2026
    Outcome of Board Meeting scheduled to be held on 29th May, 2026
  14. Board Meeting21 May 2026
    Board Meeting Intimation for Approving Audited Financial Ressults
    Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve 1. To consider and approve ....
  15. Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A30 Apr 2026
    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
    <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
  16. EGM28 Apr 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
    Voting Result and Scrutinizer''s Report for EGM held on 28th April, 2026 through VC-OAVM
  17. EGM28 Apr 2026
    Shareholder Meeting / Postal Ballot-Outcome of EGM
    Outcome and Proceedings of the Extraordinary General Meeting held on 28th April, 2026, through (VC-OAVM).
  18. Reg.24(A)-Annual Secretarial Compliance21 Apr 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Non-Applicability of Reg 24(A) of SEBI (LODR) Regulation, 2015 Annual Secretarial Compliance Report.
  19. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201814 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under regulation 74(5) of SEBI (Depositories Participants) Regulation 2018
  20. Record Date6 Apr 2026
    Record Date
    Intimation of record date i.e. 17th April, 2026, for the E-voting process pursuant to the Extraordinary General Meeting scheduled to be held on 28th April, 2026

Frequently Asked Questions

Where can I download the annual report of Asston Pharmaceuticals Ltd.?
Annual reports of Asston Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Asston Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Asston Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Asston Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Asston Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Asston Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Asston Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Asston Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Asston Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Asston Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Asston Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Asston Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Asston Pharmaceuticals Ltd. is INE0SJX01015. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Asston Pharmaceuticals Ltd. listed?
Asston Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is 544445-BOM and the BSE code is -.
Where can I find the shareholding pattern of Asston Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Asston Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Asston Pharmaceuticals Ltd. on Sharpely?
Share price data for Asston Pharmaceuticals Ltd. is updated as of 24 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.